Bal Pharma Ltd.

View in App
89.50 +0.25 ▲0.3%

06 June 2023, 09:15:54 AM
Volume: 243

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.balpharma.com
Market Cap 140.25 Cr.
Enterprise Value(EV) 261.67 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.88 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 47.73 Trailing Twelve Months Ending 2022-12
Industry PE 33.51 Trailing Twelve Months Ending 2022-12
Book Value / Share 38.96 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.30 Calculated using Price: 89.50
Dividend Yield 1.12 Period Ending 2022-03
No. of Shares Subscribed 1.57 Cr. 15,689,872 Shares
FaceValue 10
About Bal Pharma Ltd.
Bal Pharma, incorporated in 1987 is engaged in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

Bal Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bal Pharma Ltd. Performance

View details >>
1 Day
+0.28%
1 Week
+7.83%
1 Month
+9.01%
3 Month
+24.05%
6 Month
+0.34%
1 Year
-10.19%
2 Year
-11.47%
5 Year
+23.36%
10 Year
+473.72%

Bal Pharma Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.03 7.00 0.49 -0.69 0.59 3.27 -21.65 8.97 10.34
Return on Capital Employed (%) 14.05 10.88 7.35 7.59 7.45 6.88 -0.44 9.72 12.33
Return on Assets (%) 3.50 2.23 0.14 -0.18 0.15 0.83 -5.16 1.97 2.28

Bal Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 50 55 55 62 65 67 52 54 59 60
Non Curr. Liab. 18 16 45 30 46 38 34 34 36 42
Curr. Liab. 87 92 111 143 154 163 159 153 166 187
Minority Int. 0 0 -2 -5 -6 -7 0 0 0
Equity & Liab. 155 164 211 233 260 261 238 240 261 290
Non Curr. Assets 60 59 68 69 75 78 81 76 76 76
Curr. Assets 95 105 143 165 185 183 157 164 185 214
Misc. Exp. not W/O
Total Assets 155 164 211 233 260 261 238 240 261 290

Bal Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 179 187 198 229 209 225 171 251 281 296
Other Income 1 1 1 3 2 1 2 1 5 4
Total Income 180 188 200 232 211 226 173 252 286 300
Total Expenditure -161 -170 -183 -214 -192 -207 -166 -226 -257 -275
PBIDT 19 18 16 18 19 19 7 26 29 25
Interest -7 -7 -6 -8 -9 -13 -13 -12 -11 -11
Depreciation -5 -7 -7 -6 -7 -6 -8 -10 -9 -9
Taxation -2 -1 -2 -3 -3 2 1 1 -3 -1
Exceptional Items
PAT 5 4 0 0 0 2 -13 5 6 3
Minority Interest 0 1 2 2 2 1 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 5 4 1 2 3 4 -12 5 6 3
Adjusted EPS 5 3 1 1 2 3 -9 3 4 2

Bal Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2011-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 13 15 -19 6 1 8 23 22 28
Cash Fr. Inv. -2 -7 -5 -14 -8 -4 -8 -5 -6 -9
Cash Fr. Finan. -2 -8 -7 32 -6 4 0 -20 -17 -18
Net Change 1 -2 2 -1 -8 1 0 -1 0 0
Cash & Cash Eqvt 2 3 5 5 -25 3 2 1 1 1

Bal Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 44.98 44.84 46.87 49.57 49.57 52.00 52.00 51.61 51.61
Public 55.02 55.16 53.13 50.43 50.43 48.00 48.00 48.39 48.39
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bal Pharma Ltd. Announcements

View details >>
Fri, 02 Jun 2023
Updates
Bal Pharma Limited has informed the Exchange regarding 'Appointment of Additional Director'.
Thu, 01 Jun 2023
Updates
Bal Pharma Limited has informed the Exchange regarding 'Appointment of Additional Director'.
Thu, 01 Jun 2023
Publish Audited Results
Bal Pharma Limited has informed the Exchange about Published Audited Financial Results of the Company ( Standalone and Consolidated ) for the quarter and F.Y ended 31.03.2023.

Bal Pharma Ltd. Technical Scans

View details >>
Mon, 05 Jun 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
CCI Overbought Zone CCI Overbought Zone

Bal Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 242,260.85 1,004.15 -0.5%
Divi's Laboratories Ltd. 91,882.66 3,459.10 -0.1%
Cipla Ltd. 78,680.17 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. 76,651.29 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. 71,154.71 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. 60,075.76 1,767.25 -0.4%
Mankind Pharma Ltd. 57,049.80 1,444.20 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.59 1,004.15 -0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 50.39 3,459.10 -0.1%
Cipla Ltd. Consolidated 2023-03 28.08 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.04 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.87 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.12 1,767.25 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 42.73 1,444.20 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.33 1,004.15 -0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7.20 3,459.10 -0.1%
Cipla Ltd. Consolidated 2023-03 3.36 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.50 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.66 1,767.25 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 5.49 1,444.20 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,004.15 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,459.10 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,767.25 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,444.20 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,004.15 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,459.10 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,767.25 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,444.20 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,004.15 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,459.10 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,767.25 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,444.20 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,004.15 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,459.10 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,767.25 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,444.20 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,004.15 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,459.10 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.65 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,622.10 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,963.35 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,767.25 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,444.20 +1.4%

Bal Pharma Ltd. FAQ's

What is Bal Pharma share price?
Can I buy Bal Pharma shares now?
What is the Dividend Yield of Bal Pharma?
What is the Market Cap of Bal Pharma?
What are the key metrics to analyse Bal Pharma?
What is the 52 Week High and Low of Bal Pharma?
What is the trend of Bal Pharma share price?